Real Money authors - Mark Abssy

Mark Abssy

Mark Abssy is the Head of Indexing at Tematica Research focused on index and ETP development. He has product development/management experience with ETFs, ETNs, closed-end funds, mutual funds, listed derivatives and has been directly involved in the development of a number of innovative investment products across multiple issuers including FAN, HACK, SKYY, YYY, IPAY, ISRA, GAMR, CNCR, JGLD, DTOX in the US and ISPY, FOOD, CYBR, DIGI and DTOX in Europe. In his 25 year career he has held product development and management positions at NYSE|ICE, ISE ETF Ventures, Morgan Stanley, Fidelity Investments and Loomis Sayles.  He received a BSBA from Northeastern University with a focus in Finance and International Business.
Email Mark Abssy

Recent Articles By The Author

This ETF Might Float Your Boat If You're Looking to Capitalize on Shipping

Supply chain issues would indicate that investing in the shipping space might produce a payoff; here are a few ways to do it, though I favor one in particular.

ETFs Trade Like Stocks, Right? Not Exactly

Where the comparison stops working is when investors make assumptions about comparing stock and ETF price discovery mechanisms and liquidity.

With BAD and VICE ETFs, the Devil Is in the Details

Will these exchange-traded funds pay off or send your portfolio up in a 'PUF'?

My ETF Bet for 2022? It Really Glitters

Here's why gold funds could shine in the new year.

The Investor Who Wants to Do Well, and Good, 'OWNS' These ETFs

Let's examine several exchange-traded funds that help you invest to 'make an impact.'

JPMorgan's Climate Change Solutions ETF Runs a Little Too Hot for Me

This JPMorgan fund has a lot to like, but does it have a solution to climate change? It depends on how long you want to let the Earth simmer.

Rollercoasters Not Your Thing? These ETFs Have a Way to Reduce Black Swan Risk

Most investors don't have the foresight or ability to move fast enough when 'stuff ' hits the fan. Mixing options with Treasuries can help.

Let's Check Up on 2 Immunology-Focused Oncology ETFs

Here we'll look at the iShares Genomics Immunology and Healthcare ETF and the Cancer Immunotherapy ETF to see how they stack up.

Meet the New ETF on the Block(chain)

Let's make sense of investing in non-fungible tokens as they meet exchange-traded funds with the recent launch of the Defiance Digital Revolution fund.

Let's Unroll Two Cannabis-Related ETFs

Let's review Advisor Shares Pure Cannabis and Amplify Seymour Cannabis ETFs -- and what do swaps have to do with the 'sticky icky.'

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight